Virus Diseases clinical trials

Explore recruiting virus diseases clinical trials.

Recruiting virus diseases studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Virus Diseases trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Paxlovid long covid-19 prevention trial with recruitment in the community in Norway

Norway

Therapeutic confirmatory (Phase III) EU CTIS Study details

A phase IV study to investigate the immunogenicity of the Seqirus licensed MF59 adjuvanted zoonotic influenza vaccine (H5N8) in adults previously vaccinated in 2009 with the Matrix M adjuvanted virosomal influenza (H5N1) vaccine compared to H5 naïve adults.

Norway

Therapeutic use (Phase IV) EU CTIS Study details

Phase I Study of Plitidepsin Administered Intravenously as a Single Dose in Healthy Volunteers

Spain

Human Pharmacology (Phase I)- Other EU CTIS Study details

Phase III, randomized, observer-blind, placebo-controlled, multi-center, multinational study to evaluate the efficacy, immunogenicity, and safety of a Respiratory Syncytial Virus vaccine in infants and toddlers (PEARL)

Germany, Spain, Finland

Therapeutic confirmatory (Phase III) EU CTIS Study details

CYMEVALIII - Prenatal treatment of congenital cytomegalovirus infection with letermovir randomized against valaciclovir (CYMEVAL) III

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Plitidepsin in Adults with Post COVID-19 Condition

Spain

Therapeutic confirmatory (Phase III) EU CTIS Study details

Virus Diseases trials by city

Virus Diseases in Toronto Virus Diseases in Vancouver Virus Diseases in Montreal Virus Diseases in Calgary Virus Diseases in Edmonton Virus Diseases in Ottawa Virus Diseases in Winnipeg Virus Diseases in Quebec City Virus Diseases in Hamilton Virus Diseases in Kitchener Virus Diseases in London Virus Diseases in Halifax Virus Diseases in New York Virus Diseases in Los Angeles Virus Diseases in Chicago Virus Diseases in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease